Literature DB >> 34783970

Utility of Cyst Fluid Carcinoembryonic Antigen in Differentiating Mucinous and Non-mucinous Pancreatic Cysts: An Updated Meta-Analysis.

Imadh Khan1, Muhammad Baig2, Thrisha Bandepalle1, Srinivas R Puli1.   

Abstract

BACKGROUND: Mucinous pancreatic cysts are considered premalignant and managed differently compared to benign pancreatic cystic lesions. The aim of this updated meta-analysis is to assess the diagnostic accuracy of cyst carcinoembryonic antigen (CEA) in differentiating between mucinous and non-mucinous pancreatic cysts.
METHODS: Studies comparing the diagnostic accuracy of CEA (cutoff level of 192 ng/mL) in differentiating between mucinous and non-mucinous pancreatic cysts were searched in Medline, Ovid journals, Medline nonindexed citations, and Cochrane Central Register of Controlled Trials and Database of Systematic Reviews. Pooled estimates of diagnostic precision were calculated using random and fixed effects models.
RESULTS: Initial search identified 526 reference articles, of these 34 relevant articles were selected and reviewed. Data were extracted from 15 studies (n = 2063) which met the inclusion criteria. The pancreatic cystic fluid CEA level at a 192 ng/mL cutoff value had pooled specificity of 88.6% (95% CI 85.9-90.9) and pooled sensitivity was found to be 60.4% (95% CI 57.7-62.9). The pooled positive likelihood ratio was 4.5 (95% CI 2.9-6.9) and the pooled negative likelihood ratio was 0.45 (95% CI 0.38-0.52). The pooled diagnostic odds ratio, the odds of having mucinous cyst with elevated CEA, was 11.4 (95% CI 6.9-18.7). The P for chi-squared heterogeneity for all the pooled accuracy estimates was > 0.10.
CONCLUSIONS: This meta-analysis suggests that the cyst fluid CEA level at a 192 ng/mL cutoff value is highly specific in the diagnosis of mucinous cystic lesions with reasonable sensitivity.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Carcinoembryonic antigen; Mucinous cyst; Non-mucinous cyst; Pancreatic cancer; Pancreatic cyst

Mesh:

Substances:

Year:  2021        PMID: 34783970     DOI: 10.1007/s10620-021-07315-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  7 in total

1.  A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints.

Authors:  Roger M Harbord; Matthias Egger; Jonathan A C Sterne
Journal:  Stat Med       Date:  2006-10-30       Impact factor: 2.373

2.  A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients.

Authors:  Peter J Allen; Michael D'Angelica; Mithat Gonen; David P Jaques; Daniel G Coit; William R Jarnagin; Ronald DeMatteo; Yuman Fong; Leslie H Blumgart; Murray F Brennan
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

Review 3.  Cystic lesions of the pancreas: challenging issues in clinical practice.

Authors:  Hyoung-Chul Oh; Myung-Hwan Kim; Chang Yun Hwang; Tae Yoon Lee; Sang Soo Lee; Dong-Wan Seo; Sung Koo Lee
Journal:  Am J Gastroenterol       Date:  2007-12-11       Impact factor: 10.864

4.  Cytopathological Analysis of Cyst Fluid Enhances Diagnostic Accuracy of Mucinous Pancreatic Cystic Neoplasms.

Authors:  Wesley K Utomo; Henri Braat; Marco J Bruno; Casper H J van Eijck; Bas Groot Koerkamp; Nanda C Krak; Adriaan van de Vreede; Gwenny M Fuhler; Maikel P Peppelenbosch; Katharina Biermann
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

5.  The Combination of Cyst Fluid Carcinoembryonic Antigen, Cytology and Viscosity Increases the Diagnostic Accuracy of Mucinous Pancreatic Cysts.

Authors:  Se Hun Oh; Jong Kyun Lee; Kyu Taek Lee; Kwang Hyuck Lee; Young Sik Woo; Dong Hyo Noh
Journal:  Gut Liver       Date:  2017-03-15       Impact factor: 4.519

6.  The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews.

Authors:  Penny Whiting; Anne W S Rutjes; Johannes B Reitsma; Patrick M M Bossuyt; Jos Kleijnen
Journal:  BMC Med Res Methodol       Date:  2003-11-10       Impact factor: 4.615

7.  The value of KRAS mutation testing with CEA for the diagnosis of pancreatic mucinous cysts.

Authors:  Abdurrahman Kadayifci; Mohammad Al-Haddad; Mustafa Atar; John M Dewitt; David G Forcione; Stuart Sherman; Brenna W Casey; Carlos Fernandez-Del Castillo; C Max Schmidt; Martha B Pitman; William R Brugge
Journal:  Endosc Int Open       Date:  2016-03-24
  7 in total
  2 in total

1.  Translation of a Protease Turnover Assay for Clinical Discrimination of Mucinous Pancreatic Cysts.

Authors:  Vallabh Suresh; Kaleb Byers; Ummadisetti Chinna Rajesh; Francesco Caiazza; Gina Zhu; Charles S Craik; Kimberly Kirkwood; Vincent Jo Davisson; Daniel A Sheik
Journal:  Diagnostics (Basel)       Date:  2022-05-28

Review 2.  Pancreatic Incidentaloma.

Authors:  Miłosz Caban; Ewa Małecka-Wojciesko
Journal:  J Clin Med       Date:  2022-08-09       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.